DELIVERABLES

 
D8.1 – Communication Plan and Tools (M3) – CO

D1.1 – Project Handbook (M4) – CO

D6.1 – Report on the protocol for the clinical study on MD (M4) – CO

D8.2 – Project Brochure (M4) – PU

D8.3 – MedBioinformatics website (M4) – PU

D1.2 – Quality assurance guidelines and procedure (M6) – CO

D2.1 – Guidelines for biomedical informatics software development (M6) – CO

D2.2 – Interactive user requirements – Iteration 1 (M6) – CO

D3.1 – Research paper on new algorithms to unveil the genetic architecture of phenotypes (M12) – CO

D4.1 – Disease Biomarker Browser (DBB), first prototype (M12) – CO

D4.2 – Report on development of a clinical diseasome including temporal disease trajectories (M12) – CO

D4.3 – Report on the development of the trait-based diseasome (M12) – CO

D2.3 – Interactive user requirements – Iteration 2 (M15) - CO

D4.4 – Disease Trajectory Comorbidity Browser (DTCB), first prototype (M15) – CO

D5.1 – Database of markers of prognosis and response to cancer therapies (M18) – CO

D8.4 – Intermediate report on dissemination activities (M18) – CO

D1.3 – Interim assessment of the Project (M20) – CO

D5.2 – Compound-target interactions database (M20) – CO

D5.3 – TCGI 2.0 Prototype (M20) – CO

D8.5 – Report on business models (M20) – CO

D2.4 – Interactive user requirements – Iteration 3 (M24) – CO

D3.2 – Research paper on new algorithms for the prediction of individual phenotypes (M24) – CO

D3.3 – M3B: the MedBioinformatics Benchmarking Browser and a research paper on it (M24) – CO

D4.5 – Report on the development of a molecular diseasome (M24) – CO

D4.6 – Report on the results of the evaluation of the DBB data and tool by the experts (M30) – CO

D5.4 – TIMMA v2.0 implementation ready to be used in the several cancer case studies (M30) – CO

D6.2 – Report on the case study on biomarkers of AD (M30) – CO

D7.1 – Report on the case study on AD and cancer comorbidities (M30) – CO

D7.2 – Report on the case study on cancer and depression comorbidities (M32) – CO

D5.5 – Report on the testing of the MedBioinformatics applications in the PSMAR’s use cases (M33) – CO

D5.6 – Report on the testing in the MedBioinformatics applications in the VHIO’s use cases (M33) – CO

D5.7 – Report on the testing in the MedBioinformatics applications in the FIMM’s use cases (M33) – CO

D6.3 – Report on the comparative analysis of MD and Alcohol-induced MD biomarkers (M33) – CO

D7.3 – Report on the case study on the effect of chronic pharmacologic treatment in cancer and CNS comorbidities (M34) – CO

D2.5 – Software tools evaluation (M36) – CO

D2.6 – Software benchmarking (M36) – CO

D3.4 – The GePhEx software and a research paper on it (M36) – CO

D4.7 – Report on the results of the evaluation of the DTCB by the experts (M36) – CO

D4.8 – Disease Biomarker Browser (DBB), final version (M36) – CO

D4.9 – Disease Trajectory Comorbidity Browser (DTCB), final version (M36) – CO

D5.8 – Final version of the TCGI 2.0 ready to be used by partners and distributed to others (M36) – CO

D5.9 – Results of testing TIMMA v2.0 in AML cases (M36) – CO

D6.4 – Report on biological hypothesis for the AD-MD comorbidity (M36) – CO

D8.6 – Business and sustainability plan (M36) – CO

D8.7 – Final report on outreach and dissemination activities (M36) - PU